Hi Shadows,

Regarding Jupiter Bio, the company has been clocking good results since a long time but somehow catches market fancy only when there is a roaring midcap and smallcap rally which seems to be missing currently.

It manufactures drug intermediates, especially peptides. It has got a good product called Revitress gel marketed by a subsidiary called Sven Genetech which is to arrest hair fall especially in women and the company people claim it to be no.1 product in women's hair loss category, although I doubt it. Sven also has other prescription products although how much it contributes to the overall revenues and profitability remains to be checked.

I think Ranbaxy had taken some stake in the company and what happened after Dai Ichi takeover I don't know.

Charts wise, the stock needs to close above 91-92 (its earlier high in July09) with convincing volumes to give a good rise.

Bought this one 3 months back.

Because it is cheap?

 

Edited by shadows - 25/Sep/2009 at 6:13pm